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Introduction
Bladder cancer is a highly prevalent disease, especially in North European countries such as Scotland and Denmark in situ with early invasion of the bladder wall 4, 5 .
Propolis is a resinous substance that honey bees collect from botanical sources and mix with their own saliva. It helps maintain aseptic conditions and appropriate temperature in the hive. The diversity of plants in the vicinity of the hive is the main factor determining the chemical composition of propolis 6, 7 .
Green propolis, so called because of the presence of green pigment from the native shrub species Baccharis dracunculifolia 6 , is a Brazilian variety of propolis known for its many pharmacological properties. Among the most promising is the anticarcinogenic action of its constituents, some of which have been tested in laboratory animals and human cell culture [8] [9] [10] . The laboratory animal facility and the handling of animals and materials followed WHO safety guidelines 15, 16 .
N-Butyl-N-[4-hydroxybutyl] nitrosamine (BBN)
BBN was purchased from TCI America (9211 N.
Harborgate Street, Portland, OR 97203; CAS #3817-11-6) and stored at 4°C. Each vial containing 97% BBN was diluted to 2.5%
in mother solution and rediluted to 0.05% in potable water every other day for 14 weeks.
L-Lysine
The amino acid L-lysine monohydrochloride (C 6 H 14 N 2 O 2 •HCl; CAS #657-27-2) was prepared for extraction as a distilled water solution at 8% and administered in doses of 150 mg/kg.
Experimental procedures
The study was previously approved by the UFC Ethics .
Statistical analysis
Quantitative variables, both continuous and discrete, 
FIGURE 4 -(A, B, C, D and E)
Bladder carcinomas (Group IV, rats 1,2,3,4 and 5); 4 (F, G), and 4 H kidney, ureter carcinoma and ultrasound scan (31ª week) bladder tumor (Group IV, rat 6: This animal was excluded from the study because the bladder has been lost). Table 1 shows the incidence of benign, premalignant and malignant changes detected in the histopathological study.
Chemoprevention with green propolis green propolis extracted in L-lysine versus carcinogenesis promotion with L-lysine in N-Butyl-N-[4-hydroxybutyl] nitrosamine (BBN) induced rat bladder cancer
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Discussion
The lower incidence of carcinomas in animals treated chronically with propolis (administered prior to and concomitantly with carcinogen), Group I, in relation to the incidence of carcinomas in the control group which received only carcinogen (Group VI), suggests that propolis has a chemopreventive effect against bladder carcinogenesis, when administered prior to the administration of BBN and continuously.
The findings are similar to the reported reduction of the incidence of tumors in mice with induced carcinogenesis of the skin 9 and lung 17 , when treated with Brazilian propolis. However, in these studies, propolis was not given prior to carcinogen but only concomitantly.
Raw green propolis, in the present study, contained 13.60 mg artepillin C per gram of propolis, but only one derivative of artepillin C was identified in lyophilized propolis.
The alcoholic extract of green propolis containing artepillin C and synthetic artepillin C reduced lung carcinogenesis in mice 8 This indicates that other compounds were responsible for the decrease in the incidence of carcinogenesis in Group I. Is this an antioxidant or immunomodulatory effect?
The product of lyophilized propolis in the present study was submitted to an antioxidant assay using the 1,1-diphenyl- The incidence of tumors in rats treated with propolis by the subcutaneous route in the present study did not differ significantly in relation to the respective control.
Propolis not only from Brazil but other countries is studied in parallel with compounds of pharmacological interest isolated from them, such as artepilin C, CAPPE (caffeic acid phenethyl ester), p-coumaric acid, caffeic acid, quercetin, chrysin and naringenin, showing reduction of tumors in animals and cytotoxic effects in cultured human tumor cells [21] [22] [23] [24] [25] .
When comparing the incidence of Group I with that of the group that received propolis for 40 weeks, without administration of propolis prior to the carcinogen (Group III), a lower incidence of carcinomas was observed; that is, there was also a better protection by propolis in the group that was previously treated with propolis. However, there was no difference between Group III and the control (Group VI).
The variables analyzed here, including incidence, These results showed that both propolis and L-lysine at doses of 150 mg/kg body weight, for 40 weeks, are not genotoxic to bone marrow or peripheral blood leukocytes. Rather, the results suggest that propolis as well as L-lysine is efficient in protecting against genotoxicity in bone marrow and peripheral blood leukocytes, when comparing all the groups treated with carcinogens to the control groups V and VI, which received BBN and water oral and subcutaneous, respectively. These results contrasted with those of other investigators 30 , who identified acute mutagenic potential in vivo for Brazilian green propolis. However, it is necessary to point out that we used a much lower dose of propolis than that utilized in the cited study, and that the lack of artepillin C could have also had an influence. Therefore, we believe that it is essential to know the ranges of the genotoxic dose and chemoproventive dose for the safe use of propolis. Our study shows that the chronic use of propolis at low concentrations in rats is not genotoxic and is capable of protecting against the genotoxicity of BBN.
With respect to L-lysine, although it has a promoter action (not genotoxic) in bladder carcinogenesis, it is also not genotoxic to bone marrow or peripheral blood leukocytes at the doses tested in the animals.
Conclusions
The green propolis (WSDP) has chemopreventive activity against carcinogenesis of the bladder in rats when administered prior to the carcinogen and continuously and that L-lysine promotes carcinogenesis of the bladder induced by BBN.
